Amiodarone-induced hepatotoxicity varies from asymptomatic serum aminotransferase
elevation to severe liver disease. Aspartate aminotransferase, alanine aminotransferase …

DISCUSSION Amiodarone is becoming the drug of choice in the treatment of atrial
fibrillation, particularly in the postsurgical setting (1, 2). However, it is associated with many …

Aims Not all patients at risk for sudden cardiac death (SCD) are eligible for, or have access
to implantable cardioverter defibrillator (ICD) implantation. There are conflicting data …

Objectives We sought to develop an explicit evidence‐based model of medication
monitoring and to evaluate monitoring practices and adverse drug events in patients taking …

Background: Amiodarone is associated with dysfunction of the thyroid. Concerns have
arisen regarding the potential for adverse effects with generic formulations of amiodarone …

The aim of this work was to compare hepatocellular toxicity and pharmacological activity of
amiodarone (2-n-butyl-3-[3, 5 diiodo-4-diethylaminoethoxybenzoyl]-benzofuran; B2-O-Et-N …

This analysis of the morphology of suspected amiodarone (AD) liver disease is based on a
study of liver specimens from 17 individuals. Changes similar to alcoholic liver injury were …

Background: Amiodarone treatment frequently causes adverse reactions. Clinical guidelines
warrant a comprehensive assessment prior to chronic treatment with amiodarone and …

Hepatic dysfunction, most commonly an elevation of aminotransferases, develops in 15% to
40% of patients receiving amiodarone (1). However, acute hepatitis induced by parenteral …

Objectives. To review the rationale and development of a multidisciplinary amiodarone
clinic, and document the clinical outcomes resulting from its implementation. Methods. A …